Evidence map›Paper›PMID 31248366›Full record

Observational studyBMC gastroenterology2019

Healthcare use by 30,000 patients with irritable bowel syndrome (IBS) in France: a 5-year retrospective and one-year prospective national observational study.

Jean-Marc Sabaté, Sébastien Rivière, Pauline Jouet, Christelle Gastaldi-Menager, Anne Fagot-Campagna, Philippe Tuppin

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jean-Marc SabatéService de Gastroentérologie, Hôpital Avicenne AP-HP, INSERM U-987, 175 rue de Stalingrad, 93000, Bobigny, France.
Sébastien RivièreCaisse nationale de l'Assurance maladie (CNAM) - Direction de la Stratégie des Études et des Statistiques, 26-50 avenue du Professeur André Lemierre, F-75986, Paris, Cedex 20, France.
Pauline JouetService de Gastroentérologie, Hôpital Ambroise Paré AP-HP, 9 avenue Charles-de-Gaulle, 92104, Boulogne-Billancourt, France.
Christelle Gastaldi-MenagerCaisse nationale de l'Assurance maladie (CNAM) - Direction de la Stratégie des Études et des Statistiques, 26-50 avenue du Professeur André Lemierre, F-75986, Paris, Cedex 20, France.
Anne Fagot-CampagnaCaisse nationale de l'Assurance maladie (CNAM) - Direction de la Stratégie des Études et des Statistiques, 26-50 avenue du Professeur André Lemierre, F-75986, Paris, Cedex 20, France.
Philippe TuppinCaisse nationale de l'Assurance maladie (CNAM) - Direction de la Stratégie des Études et des Statistiques, 26-50 avenue du Professeur André Lemierre, F-75986, Paris, Cedex 20, France. philippe.tuppin@cnamts.fr.ORCID http://orcid.org/0000-0001-5698-9215
Conservatoire National des Arts et Métiers · FRAssistance Publique – Hôpitaux de Paris · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIrritable bowel syndrome (IBS) can be responsible for alteration in quality of life and economic burden. The aim of this study was to evaluate healthcare use related to this disorder in France.

methodsThe French health data system was used to select adults covered by the general health scheme (87% of population) through their first IBS hospitalization in 2015. We studied the healthcare refunded during the previous 5 years, 1 year before and after hospitalization.

resultsAmong 43.7 million adults who used refunded healthcare in 2015, 29,509 patients were identified (0.07, 33% males, 67% females, mean age 52 years, 30% admitted through emergency room). During their hospitalization, 33% had upper endoscopy and 64% colonoscopy. Over the five previous years, 3% had at least one hospitalization with an IBS diagnosis, 58% had abdominal ultrasonography, 27% CT scan, 21% upper endoscopy, 13% colonoscopy and 83% a gastroenterologist visit. The year before, these rates were respectively: 0, 36, 16, 6, 4 and 78%. Some of those rates decreased the year after the hospitalization with respectively: 1, 27, 13, 5, 4 and 19%. The year before, 65% had at least one CRP dosage (13% three or more), 58% a TSH dosage (7%) and 8% a test for coeliac diseases (1%) and the year after: 44% (8%), 43% (5%) and 3% (0.3%). At least one refund of a drug used to treat IBS was found for 85% of patients 5 years before, 65% one year before and 51% one year after.

conclusionThis first study using French health data system for healthcare consumption assessment in IBS points out the repetition of outpatient visits, examinations and in particular radiological examinations, without a strong decrease after hospitalization for IBS and gastroenterologist visit.

Indexed as

AdultAgedAmbulatory CareCeliac DiseaseClinical Laboratory TechniquesColonoscopyC-Reactive ProteinDatabases, FactualDrug PrescriptionsFemaleFranceGastroenterologyHospitalizationHumansInsurance, Health, ReimbursementIrritable Bowel SyndromeC-Reactive ProteinThyrotropinAmbulatory healthcare useComorbiditiesHospitalisationIrritable bowel syndromeObservational study

Identifiers

PMID31248366
PMCPMC6598248
OpenAlexW2953917065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.